Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

Silvio E. Inzucchi(Yale University), David R. Matthews(Manchester College)

Diabetes Care

April 19, 2012

10.2337/dc12-0413

Cited by 3,212

Related Papers

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

|New England Journal of Medicine|2015|11.9k

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

|New England Journal of Medicine|2017|7.7k

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

|New England Journal of Medicine|2019|6.8k

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

|Diabetologia|2012|3.9k

American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control

|Diabetes Care|2009|1.5k